ConductScience.org, home

Paper371544

Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine.

Fitch CD and 2 others. Antimicrob Agents Chemother, 1979. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine. Papers, record 371544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/371544

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.12
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fitch CDC D
2Chan RLR L
3Chevli RR

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
ChloroquineMajor topic
MalariaMajor topic
PiperidinesMajor topic
QuinolinesMajor topic
Receptors, DrugMajor topic
Animals
Drug Resistance, Microbial
Erythrocytes
Male
Mice
Plasmodium berghei

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14549967Chloroquine accumulation by erythrocytes: a latent capability.Life Sci1974https://conductscience.org/library/papers/4549967PubMed
298104Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine).Antimicrob Agents Chemother1978https://conductscience.org/library/papers/98104PubMed
3406829Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/406829PubMed
4358916Erythrocyte surface: novel determinant of drug susceptibility in rodent malaria.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/358916PubMed
5339856The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490).Ann Trop Med Parasitol1977https://conductscience.org/library/papers/339856PubMed
6337017Chloroquine susceptibility in malaria: dependence on exposure of parasites to the drug.Life Sci1977https://conductscience.org/library/papers/337017PubMed
7326337Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.Br Med J1977https://conductscience.org/library/papers/326337PubMed
8926111Molecular structural effects involved in the interaction of quinolinemethanolamines with DNA. Implications for antimalarial action.J Med Chem1977https://conductscience.org/library/papers/926111PubMed
94206524Infections with Plasmodium falciparum and Plasmodium vivax in the owl monkey--model systems for basic biological and chemotherapeutic studies.Trans R Soc Trop Med Hyg1973https://conductscience.org/library/papers/4206524PubMed
104600044High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei.J Clin Invest1974https://conductscience.org/library/papers/4600044PubMed
115115690Antimalarials. 7. Bis(trifluoromethyl)- -(2-piperidyl)-4-quinolinemethanols.J Med Chem1971https://conductscience.org/library/papers/5115690PubMed
124217585Chloroquine-resistant Plasmodium falciparum: effect of substrate on chloroquine and amodiaquin accumulation.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4217585PubMed
134208293Chloroquine-resistant Plasmodium falciparum: difference in the handling of 14C-amodiaquin and 14C-chloroquine.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4208293PubMed
144619059Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria.Bull World Health Organ1974https://conductscience.org/library/papers/4619059PubMed
15488Amodiaquin accumulation by mouse erythrocytes infected with Plasmodium berghei.J Pharmacol Exp Ther1975https://conductscience.org/library/papers/488PubMed
161105787Mefloquine (WR 142,490) in the treatment of human malaria.Science1975https://conductscience.org/library/papers/1105787PubMed
171104805Chloroquine resistance in malaria: variations of substrate-stimulated chloroquine accumulation.J Pharmacol Exp Ther1975https://conductscience.org/library/papers/1104805PubMed
18769678Suppressive activity of mefloquine in sporozoite-induced human malaria.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/769678PubMed
195271747Chloroquine resistance in malaria: a deficiency of chloroquine binding.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/5271747PubMed
205937128Chloroquine: physiological basis of drug resistance in Plasmodium berghei.Science1966https://conductscience.org/library/papers/5937128PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
26576290Complex Membrane Channel Blockade: A Unifying Hypothesis for the Prodromal and Acute Neuropsychiatric Sequelae Resulting from Exposure to the Antimalarial Drug Mefloquine.J Parasitol Res2015https://conductscience.org/library/papers/26576290PubMed
24002481Investigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasma.Am J Trop Med Hyg2013https://conductscience.org/library/papers/24002481PubMed
6998717Binding of antimalarial drugs to hemozoin from Plasmodium berghei.Experientia1980https://conductscience.org/library/papers/6998717PubMed
6979309The antimalarial drug mefloquine binds to membrane phospholipids.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6979309PubMed
3893840Clinical pharmacokinetics of antimalarial drugs.Clin Pharmacokinet1985https://conductscience.org/library/papers/3893840PubMed
3555581Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3555581PubMed
2208897Clinical pharmacokinetics of mefloquine.Clin Pharmacokinet1990https://conductscience.org/library/papers/2208897PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/371544

GET https://conductscience.org/api/papers/v1/371544/authors